Keyphrases
Deviated Nose
66%
Parry-Romberg Syndrome
66%
Psoriasis
66%
Double-blind Randomized Controlled Trial
66%
Androgenetic Alopecia
66%
Metabolic Syndrome Parameters
66%
Metabolic Syndrome
47%
TrichoScan
38%
Indonesia
38%
Jakarta
38%
Single Spin
33%
Double Spin
33%
Extrinsic Atopic Dermatitis
33%
Cimetidine
33%
Pemphigus Vulgaris
33%
Challenges in Management
33%
Facial Skin Rejuvenation
33%
Narrowband Ultraviolet B Phototherapy
33%
Vitiligo Patients
33%
Fractional CO2 Laser
33%
Platelet-rich Plasma
33%
Metabolic Syndrome Prevalence
33%
Clinical Manifestations
33%
Microneedles
33%
Curcuma Xanthorrhiza
33%
Adjuvant Therapy
33%
General Hospital
33%
Adipose-derived Mesenchymal Stem Cells (ADMSCs)
33%
Fusidic Acid
33%
Hard to Treat
33%
Thrombocyte Count
33%
Psoriatic Patients
33%
Mesenchymal Stem Cell-derived Exosomes
33%
Ointment
33%
Histopathological Features
33%
Deoxyribonucleic Acid
33%
Randomised Double-blind Clinical Trial
33%
Centrifugation Method
33%
Psoriasis Severity
33%
Stable Vitiligo
33%
Punch Grafting
33%
Vitiligo
33%
Clinical Improvement
33%
Skin Lesions
33%
Leprosy Patients
33%
Mycobacterium Leprae
33%
Skin Surface
33%
Hospital-based
33%
Xerosis Cutis
33%
Adult Atopic Dermatitis
33%
Medicine and Dentistry
Psoriasis
100%
Vitiligo
66%
Parry-Romberg Syndrome
66%
Placebo
38%
Clinical Trial
37%
Prevalence
36%
Rejuvenation
33%
Facial Skin
33%
Adipose-Derived Mesenchymal Stem Cell
33%
Carbon Dioxide
33%
Cross Sectional Study
33%
Metabolic Syndrome
33%
Pemphigus vulgaris
33%
DNA
33%
Skin Surface
33%
Randomized Controlled Trial
33%
Fusidic Acid
33%
Male Type Alopecia
33%
Thrombocyte Rich Plasma
33%
Human Immunodeficiency Virus
33%
Mycobacterium leprae
33%
Skin Defect
33%
Platelet
33%
Brain Ischemia
33%
Alopecia Areata
33%
Pemphigus
33%
Midazolam
33%
Cyclosporine
26%
Apoplexy
26%
Psoriasis Area and Severity Index
24%
Septoplasty
22%
Sweat Gland
16%
Polymerase Chain Reaction
16%
Multibacillary Leprosy
16%
Acid Fast Bacterium
16%
Nabumetone
16%
Minoxidil
16%
Tibia
16%
Disease
15%
Melanocyte
14%
Folic Acid
13%
Pyridoxine
13%
Methotrexate
13%
Combination Therapy
13%
Blister
11%
Degenerative Disease
11%
Mouth
11%
Pathophysiology
11%
Pediatrics
11%
Diagnosis
11%
Pharmacology, Toxicology and Pharmaceutical Science
Male Type Alopecia
100%
Randomized Controlled Trial
66%
Atopic Dermatitis
66%
Metabolic Syndrome X
66%
Clinical Trial
37%
Bacterial Infection
33%
Hyaluronic Acid
33%
Cimetidine
33%
Fusidic Acid
33%
Psoriasis
33%
Vitamin D
33%
Xerosis
33%
Carbon Dioxide
33%
Dermatitis
33%
Midazolam
33%
Dry Skin
33%
Brain Ischemia
33%
Chronic Wound
33%
Ciclosporin
26%
Comorbidity
22%
Nabumetone
16%
Wound Healing
14%
Pyridoxine
13%
Folic Acid
13%
Methotrexate
13%
Symptom
12%
Hydration
11%
Immunoglobulin E
10%
Side Effect
9%
Wound
9%
Clinical Feature
9%
Cross-Sectional Study
9%
Prevalence
9%
Hemoglobin A1c
9%
Hair Loss
9%
Triacylglycerol
9%
Alopecia
9%
Adverse Event
8%
Photoaging
8%
Chronic Inflammation
6%
Weakness
6%
Placebo
6%
Acetylsalicylic Acid
6%
Interferon
6%
Interleukin 4
6%
Minoxidil
6%
Antilipemic Agent
6%
Interleukin 12
6%
Antihypertensive Agent
6%
Anticoagulant Agent
6%
